LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Rutten, Guy E. H. M.
Tack, Cees J.
Pieber, Thomas R.
Ørsted, David Dynnes
Baeres, Florian M. M.
Marso, Steven P.
Buse, John B.
Funding for this research was provided by:
Novo Nordisk (DK) sponsored the LEADER trial